1. Home
  2. BNED vs ALDX Comparison

BNED vs ALDX Comparison

Compare BNED & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barnes & Noble Education Inc

BNED

Barnes & Noble Education Inc

HOLD

Current Price

$8.74

Market Cap

311.3M

ML Signal

HOLD

Logo Aldeyra Therapeutics Inc.

ALDX

Aldeyra Therapeutics Inc.

HOLD

Current Price

$4.11

Market Cap

293.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNED
ALDX
Founded
1965
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
311.3M
293.0M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
BNED
ALDX
Price
$8.74
$4.11
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.50
AVG Volume (30 Days)
551.4K
971.9K
Earning Date
09-12-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,567,800,000.00
N/A
Revenue This Year
$2.74
N/A
Revenue Next Year
N/A
$36.25
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.90
$1.14
52 Week High
$14.41
$7.20

Technical Indicators

Market Signals
Indicator
BNED
ALDX
Relative Strength Index (RSI) 51.69 31.41
Support Level $8.65 $4.67
Resistance Level $9.43 $4.91
Average True Range (ATR) 0.47 0.31
MACD 0.08 -0.08
Stochastic Oscillator 21.59 0.63

Price Performance

Historical Comparison
BNED
ALDX

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is an operator of bookstores in college and university campuses across the United States. The company is also engaged in providing digital education services. It operates in three reportable segments that include Retail offers existing and prospective clients the flexibility of physical, virtual, or custom store solutions, and wholesale is comprised of the wholesale and virtual retail fulfillment, and support operations of the MBS subsidiary, also Corporate Services represent unallocated shared-service costs which include corporate level expenses and other governance functions, including executive functions, such as accounting, legal, treasury, information technology, and human resources. It earns majority of the revenue from Retail segment.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: